Back to Search
Start Over
TCR2 Therapeutics Publishes First Peer-Reviewed Data Demonstrating Superior Anti-Tumor Activity of the Company's Novel TRuC-T Cells
- Source :
- Plus Company Updates. May 8, 2019
- Publication Year :
- 2019
-
Abstract
- UNITED STATES: TCR2 Therapeutics has issued the following press release: TCR2 Therapeutics Inc. (TCR2) (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.584938512